The recall affects Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets.
These past reviews were because of the nearness of N-nitrosodiethylamine in dynamic pharmaceutical fixings fabricated by Hetero Labs.
The recall was instigated after the impurity N-Methylnitrosobutyric acid (NMBA) was detected at levels above the acceptable daily intake levels, as specified by the FDA.
In total, this is the sixth recall that Torrent has issued regarding losartan medications, which are used to treat hypertension and nephropathy in type 2 diabetic patients. The lots include losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets.
UPDATE on angiotensin II receptor (ARB) recalls: Torrent expands its voluntary recall of losartan to include additional lots: https://t.co/4Tl2ti0tP4.
"Patients who are taking Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP should continue taking their medication, as the risk of harm to the patient's health may be higher if the treatment is stopped immediately without any alternative treatment", the FDA said, advising patients to contact their pharmacist or doctor about an alternative medication.
NMBA is a known carcinogen that is one of several impurities that have been found in blood pressure medicines during the past year.